Miles Capital’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
KFO
EAM
CTA
Miles Capital's NEO Position: Q1 2020 in Review
Miles Capital reduced its NeoGenomics (NEO) stake by 0.44% in Q1 2020, selling an estimated $1.26K and leaving 9,442 shares worth $261K. The position accounts for 0.28% of the portfolio, ranked #90.
Miles Capital first reported a position in NEO in Q2 2019 and has held it in 3 quarters since. The position peaked at $277K in Q4 2019. 272 funds tracked by Wall St. Rank hold NEO as of Q1 2020.
- Miles Capital held 9,442 shares of NeoGenomics worth $261K as of Q1 2020.
- Miles Capital sold 42 NeoGenomics shares in Q1 2020, an estimated $1.26K.
- NeoGenomics made up 0.28% of Miles Capital's portfolio in Q1 2020, its #90 holding.
- Miles Capital first reported a position in NeoGenomics in Q2 2019 and has held it in 3 quarters since.
- Miles Capital's NeoGenomics position peaked at $277K in Q4 2019.
- 272 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2020.
Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.